ClinicalTrials.Veeva

Menu

By Developing a Radiomics Model to Predict the Prognosis of Patients With Hepatocellular Carcinoma After Microwave Ablation

C

Chinese PLA General Hospital (301 Hospital)

Status

Unknown

Conditions

Hepatocellular Carcinoma

Treatments

Procedure: Microwave abaltion

Study type

Observational

Funder types

Other

Identifiers

NCT03880721
301jrcsk4

Details and patient eligibility

About

Developing a radiomics model to predict the prognosis of patients with hepatocellular carcinoma after microwave ablation to provide advice for their treatment.

Enrollment

200 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients with primary hepatocellular carcinoma in the department of interventional ultrasound, PLA general hospital, who accept MWA therapy for HCC

Inclusion criteria:

  1. Primary hepatocellular
  2. No other treatments ware performed before microwave ablation
  3. Patient has been clinically diagnosed with HCC definitely, and have a definite operational indication
  4. No extrahepatic manifestations and no evidence of vessel invasion and bile duct thrombi

Exclusion criteria

  • Exclusion criteria:

    1. Non-primary hepatocellular carcinoma or hepatic metastases
    2. Accept other treatment before microwave ablation
    3. Extrahepatic metastasis, vessel invasion or bile duct thrombi

Trial design

200 participants in 6 patient groups

Good prognosis
Treatment:
Procedure: Microwave abaltion
Poor prognosis
Treatment:
Procedure: Microwave abaltion
Recurrence
Treatment:
Procedure: Microwave abaltion
Not Recurrence
Treatment:
Procedure: Microwave abaltion
Survival
Treatment:
Procedure: Microwave abaltion
Death
Treatment:
Procedure: Microwave abaltion

Trial contacts and locations

1

Loading...

Central trial contact

Ping Liang, Dr; Jie Yu, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems